Headlines

заголовки анонсы
24.10.2026
05:31 News-Medical.Net Novel immunosuppressant improves kidney function and quality of life after transplantation

The Phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving kidney function than tacrolimus (the current standard of care) in immunosuppressive regimens in adults receiving their first kidney transplant.

Скрыть анонс
05:14 Bioengineer.org Cancer cells evade chemotherapy by entering zombie-like senescent state

Trinity College Dublin researchers found that Inhibitor of Apoptosis Proteins let tumour cells survive chemotherapy, enter premature senescence and recruit wound-healing immunity, while IAP antagonists selectively killed these senescent cells.

Скрыть анонс
03:48 Bioengineer.org Epithelial and Mesenchymal Stem Cells Shape Mammary Gland Biology

A review integrates murine, human, and bovine evidence on epithelial and mesenchymal stem cells in the mammary gland, highlighting mTORC1-dependent metabolic regulation, niche interactions, and experimental therapeutic approaches for bovine mastitis.

Скрыть анонс
02:01 Bioengineer.org Swarm of digital particles trains medical AI without sharing patient data

A particle swarm optimization strategy that dynamically selects the most informative clients in federated learning matches state-of-the-art methods for medical image classification while keeping standard FedAvg aggregation intact.

Скрыть анонс
01:50 DigitalTrends.com A new startup wants to fix the military’s working-dog shortage with cloning and gene editing

Warhound says gene editing and cloning can fix why military dog candidates fail, but questions about genes and oversight remain.

Скрыть анонс
01:44 Bioengineer.org Nurse-Led Ward Pathway Linked to Faster Recovery After Liver Transplantation

A quasi-experimental study at a Chinese transplant center found that a nurse-led pathway bypassing routine ICU care was associated with earlier feeding, mobilization and shorter hospital stays, though the historical-control design cannot prove causation.

Скрыть анонс
01:44 MedicalXpress.com Tegoprubart preserves kidney function better than tacrolimus in first-time transplant patients, trial suggests

The phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving kidney function than tacrolimus (the current standard of care) in immunosuppressive regimens in adults receiving their first kidney transplant. Kidney graft function stabilized after the first month of treatment and remained higher in tegoprubart-treated patients than in tacrolimus-treated patients at each reported time point, with a statistically significant kidney function benefit at 18 months. A recent analysis of BESTOW data found that tegoprubart also caused greater improvements in patient-reported health-related quality of life compared with tacrolimus in study participants. The findings will be presented at ASN Kidney Week 2026, Oct. 22–25.

Скрыть анонс
00:50 Bioengineer.org Seven Years On, Japanese Doctors and Public Still Hesitant About AI-Led Care

A repeated Japanese survey of physicians and the public found that intention to use relatively autonomous medical AI did not change significantly between 2018 and 2025 despite rising self-rated knowledge.

Скрыть анонс
00:33 Bioengineer.org Counting Molecular Mismatches: HLA Eplet Analysis Moves Kidney Transplant Care Toward Precision Immune Risk Assessment

A new narrative review finds that quantifying structural HLA differences between donor and recipient predicts antibody-mediated rejection risk and may guide immunosuppression, though prospective interventional evidence remains limited.

Скрыть анонс
00:33 Bioengineer.org Vulvovaginal Graft-versus-Host Disease Affects One in Four Women After Stem Cell Transplants

A retrospective French study found vulvovaginal graft-versus-host disease in 25.5% of women after allogeneic stem cell transplantation, often with late onset and severe forms.

Скрыть анонс
00:17 Phys.org Scientists demonstrate AI-designed enzyme for drug synthesis

The new RFD4-Proteina unified generative model for protein design—created by the Institute for Protein Design (IPD) in collaboration with NVIDIA—uses advanced AI to generate entirely new protein sequences and structures, achieving computational design success rates five to 10 times higher than previous models and generating candidates five to 10 times faster.

Скрыть анонс
00:02 9to5google.com Google Health 5.11 rolling out with Fitbit Air Health Guardian, improved sleep tracking, & more

Google Health 5.11 is rolling out this week as a rather big update for Fitbit trackers and the Pixel Watch. more…

Скрыть анонс
23.10.2026
23:00 ScientificAmerican.Com Warhound wants to engineer and clone military superdogs—can they do it?

The start-up is the brainchild of a founder of Anduril, the military tech firm, and Colossal Biosciences, a biotech company known for its de-extinction efforts

Скрыть анонс
22:48 Phys.org New marker panel and free web tool help track stem cells as they develop

How can the identity of pluripotent stem cells be determined more reliably during their differentiation? Researchers from the IUF—Leibniz Research Institute for Environmental Medicine and Heinrich Heine University Duesseldorf have systematically validated marker genes for this purpose and developed a web-based application for the automated classification of early cell fates. The study has been published in Stem Cell Reports.

Скрыть анонс
21:40 9to5google.com Google Health 5.11 rolling out expanded 100+ activity detection to Fitbit Air, Pixel Watch

With the Fitbit Edge announcement, Google Health previewed improved automatic activity tracking, and it’s now beginning to roll out with version 5.11 of the app. more…

Скрыть анонс
19:38 Futurity.org Could tiny robots replace open-heart surgery?

Robots the size of a pencil tip could travel through the body to deliver medicine to infections inside a beating heart.

Скрыть анонс
18:36 MedicalDaily.com Liver Transplant Candidates Who Improved Frailty Scores by 0.4 Points Had Roughly Half the Risk of Waitlist Death

A study tied modest frailty gains in a prehab program to lower waitlist death risk in liver transplant candidates. Here is what caregivers can ask the care team.

Скрыть анонс
18:32 Bioengineer.org Bibliometric review finds genome editing missing from Ficus research landscape

A systematic bibliometric analysis of 25 years of Ficus literature shows that only about 11.3 percent of publications address genomic or genetic engineering topics and that CRISPR-related keywords are absent from the field's thematic maps, revealing a translational bottleneck between rapidly expanding genomic resources and functional genome editing in figs.

Скрыть анонс
18:32 Bioengineer.org Ancient Chinese Preventive Medicine Meets AI in Proposed Digital Health Framework

Researchers propose a testable framework that pairs Traditional Chinese Medicine's preventive-treatment doctrine with digital phenotyping and dual-engine AI analysis for chronic disease control, while stressing the architecture remains clinically unvalidated.

Скрыть анонс
18:32 MedicalXpress.com AI gets more diagnoses right than generalist doctors in medical challenge

One of the many challenging parts of being a doctor is diagnosing exactly what is wrong with a patient. This is because numerous illnesses often have overlapping symptoms, which can make the diagnostic journey a long one.

Скрыть анонс
16:43 MedicalXpress.com Who decides when medical AI may be updated?

Medical AI can improve with new patient data, but every update must be checked first. Patients, equipment and ways of working change, and a model trained on older data can gradually get worse without anyone noticing.

Скрыть анонс
16:27 Phys.org A quick squeeze helps CRISPR turn skin cells into neurons more efficiently

Human cells hold about two meters (6.6 feet) of DNA, folded and compacted to fit inside a nucleus. That packing is essential for life, but it creates a problem for scientists. Some of the genes that control a cell's identity are buried so deep in tightly packed DNA that gene-targeting tools such as CRISPR activation, or CRISPRa, struggle to reach them.

Скрыть анонс
16:25 Bioengineer.org Massive Cell Atlas Reveals How Aging Blood Vessels Lose Their Regenerative Power

An integrated single-cell atlas of more than 375,000 endothelial cells from 12 human tissues identifies conserved transcriptional hallmarks of vascular aging, including inflammation, reduced angiogenic gene expression and a p21-linked senescence program.

Скрыть анонс
15:51 TechMeme.com Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from a $1.6B valuation in May 2025 (Katherine Davis/Axios)

Katherine Davis / Axios: Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from a $1.6B valuation in May 2025  —  Precision oncology biotech Pathos AI said Friday it raised a $237 million Series E round at a $3 billion post-money valuation.

Скрыть анонс
15:50 Bioengineer.org For Blood Cancer Patients, a Transplant Can Feel Like the Only Choice

A systematic review of 20 qualitative studies finds that blood cancer patients often experience hematopoietic stem cell transplantation as a constrained choice shaped by family, finances, and fears about identity rather than a free weighing of options.

Скрыть анонс
12:15 Nature.Com AI doctors’ orders come with a sky-high bill

Скрыть анонс
12:09 Nature.com (news) AI doctors’ orders come with a sky-high bill

Скрыть анонс
10:58 TheNextWeb.com Microsoft AI tool beat generalist doctors at step-by-step diagnosis

Microsoft has developed an AI diagnostic tool that solved complex medical cases more than twice as accurately as generalist doctors in a study published in Science. Unlike many medical AI systems, it works through a case step by step, deciding which questions to ask and which tests to order before reaching a diagnosis. The tool, […] This story continues at The Next Web

Скрыть анонс
10:57 South China Morning Post China’s head transplant advocate Ren Xiaoping completes landmark spinal surgery in Russia

Ren Xiaoping, who once vowed to perform the world’s first human head transplant, has operated on a patient’s severed spinal cord in a 12-hour landmark operation in Moscow, according to the Chinese surgeon and Russian state sources. Ren said the procedure was carried out at the Sklifosovsky Research Institute for Emergency Medicine in Russia last week. “It was our Guangxi University of Chinese Medicine Second Affiliated Hospital and the Russian team working together,” Ren told the South China...

Скрыть анонс
10:13 112.ua Can AI really predict cancer survival better than a doctor? I have my doubts | Devi Sridhar

Take a selfie to see how healthy you are: the idea is enticing and this new research is promising. But so many factors have been ignored The idea that a single selfie could predict how long someone with cancer may live sounds like an incredible breakthrough. AI is getting better at spotting patterns in medical data, but can it be used to reliably predict what will happen to an individual patient? I asked a clinical colleague what she thought about the recent headlines. She found it an interesting development given that doctors have long used facial appearance to assess patient health. For example, she noted that they may write “appears stated age” or “appears older than stated age” as a proxy for general health. Now, researchers from Mass General Brigham, a healthcare institution in Massachusetts, have taken this idea a step further. They have developed an AI model trained on more than 40 million facial images – called FAHR-Face – to assess biological age and predict survival

Скрыть анонс
08:18 News-Medical.Net Brain-computer interface enables unresponsive ICU patients to control sounds

Unresponsive ICU patients in a new Columbia study were able to raise and lower the frequency of a beeping tone with their minds, via noninvasive EEG electrodes that recorded and translated their brainwaves.

Скрыть анонс
07:45 MedicalDaily.com Amazon, Google, Meta and Oracle Back Electronic Prior Authorization Push for Workers and Families in Self-Funded Health Plans

Amazon, Google, Meta, Oracle, and Axon backed electronic prior authorization for self-funded plans. See what could change for workers and families.

Скрыть анонс
07:08 Arxiv.org CS HeyGen Voice: Scene-Aware Voice Cloning for Talking Videos

arXiv:2610.30470v1 Announce Type: new Abstract: Most voice-cloning systems are built for audio alone: they copy the reference recording's delivery and acoustics, so a voice cloned on a phone sounds like a phone recording whether the speaker is pictured in a studio, on a street, or in a cathedral. Speech for a talking video should sound like the pictured person speaking in the pictured place. We present HeyGen Voice, a scene-aware voice-cloning model that separates who is speaking from how and where: it keeps the speaker's voice from an everyday recording while the target image sets the delivery and acoustics. Prior image-conditioned TTS does half of this job: it either adds scene acoustics without keeping a specific speaker or infers a voice from a face. HeyGen Voice is a multimodal autoregressive transformer conditioned on the image, speaker and scene captions, and the voice recording, trained in five stages that move from multilingual TTS pretraining through simulated and real

Скрыть анонс
07:08 Arxiv.org CS Automated screening of privacy risks in medical AI

arXiv:2610.30229v1 Announce Type: new Abstract: Medical artificial intelligence (AI) models are often shared without their training data, assuming this protects the patients who contributed them. However, a model can reveal whether a patient's records were used in training, a privacy breach known as a membership inference attack. This risk is usually reported as a cohort average, which can appear negligible while individual patients are almost certainly exposed. Identifying potentially vulnerable records before developing a production model could make privacy assessment more practical. We measured each patient's vulnerability to membership inference attack, across 7,789 models trained on six clinical datasets in four modalities, including two adapted pretrained medical models. Training choices changed how many patients had high attack scores, but the patients who ranked highest by risk largely stayed the same across the configurations we tested. Stronger weight decay reduced the

Скрыть анонс
00:46 Google news Health Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’ - TechCrunch

Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’  TechCrunchMicrosoft says its AI tool is better than doctors at diagnosing conditions  The VergeMicrosoft Says Its New AI Is More Than Twice as Good at Diagnosing Diseases as Doctors  GizmodoMicrosoft Diagnostic AI Outperforms Generalist Physicians in Science Study  Unite.AICan AI help doctors avoid missed diagnoses? A new study suggests yes  TAPinto

Скрыть анонс
00:46 Google news Sci/Tech Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’ - TechCrunch

Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’  TechCrunchMicrosoft says its AI tool is better than doctors at diagnosing conditions  The VergeMicrosoft Says Its New AI Is More Than Twice as Good at Diagnosing Diseases as Doctors  GizmodoMicrosoft Diagnostic AI Outperforms Generalist Physicians in Science Study  Unite.AICan AI help doctors avoid missed diagnoses? A new study suggests yes  TAPinto

Скрыть анонс
00:33 Phys.org Natural forest regeneration helps curb spread of invasive species

The presence of non-native trees is often seen as an obstacle to the recovery of tropical forests regrowing in previously deforested areas. To better understand the behavior of these plants over time in both humid and dry forests, researchers from approximately 60 institutions analyzed data from over 1,500 areas of forest regeneration across the Americas. The results, published in the journal Nature Plants, indicate that the initial dominance of exotic species is temporary. They multiply easily during the first 10 to 20 years, taking advantage of abundant sunlight in open areas. However, they decline as native trees grow and shade the forest.

Скрыть анонс
00:33 Phys.org Canine cancer patients contribute to next-generation minimally invasive cancer therapies for dogs and humans

Natural disasters. Hikes. Long, dark nights alone. For many people, dogs offer a sense of safety and comfort in challenging or uncertain times. Cancer researchers at a new lab at Purdue University are partnering with dogs to make cancer less frightening—and less deadly—to some of humanity's very best friends using a technique called tumor ablation.

Скрыть анонс
00:24 DiscoverMagazine.com The Immortal Jellyfish Cheats Death by Reverting to a Polyp When Injured or Stressed

Meet Turritopsis dohrnii, a tiny jellyfish that can revert to an earlier stage of its life cycle when times are tough, offering insights into how to reverse aging.

Скрыть анонс
00:14 Ixbt.com CRISPR выходит за пределы лаборатории: ДНК впервые отредактировали непосредственно в организме человека

Скрыть анонс
22.10.2026
23:25 News-Medical.Net Transplanted placental cells successfully detected in mouse pancreas after birth

The pancreas is a complex organ comprising multiple cell types that regulate blood glucose levels through hormones, such as insulin, and support digestion by producing digestive enzymes.

Скрыть анонс
23:07 MedicalXpress.com New AI platform helps uncover promising cancer drug combinations

UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to overcome treatment resistance in cancer.

Скрыть анонс
23:04 Nature.Com A first for CRISPR: powerful prime editing alters DNA directly in the human body

Скрыть анонс
22:58 Nature.com (news) A first for CRISPR: powerful prime editing alters DNA directly in the human body

Скрыть анонс
22:49 MedicalXpress.com New gene-editing approach shows promise in treating Huntington's disease in mice

Huntington's disease is caused by repetitive "stutters" in DNA—specifically repeated CAG sequences—that expand abnormally over time, leading to toxic protein accumulation that contributes to the progression of the disease. There is currently no cure for this rare and fatal genetic disease.

Скрыть анонс
22:30 News-Medical.Net FDA grants accelerated approval to groundbreaking rectal cancer immunotherapy

A groundbreaking immunotherapy treatment for rectal cancer, developed through pioneering research at Memorial Sloan Kettering Cancer Center (MSK) with critical early-stage funding from Swim Across America, has received accelerated approval from the U.S. Food and Drug Administration (FDA).

Скрыть анонс
22:15 Phys.org Nontoxic 'light-activated' compound shows promise for safer 3D printing of advanced biomaterials

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a new class of light-activated compounds that could lead to safer and more versatile applications in 3D printing, cosmetics and medicine.

Скрыть анонс
21:51 Techcrunch.Com Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’

Microsoft’s new AI diagnostic system beat generalist doctors on hard cases, according to a study in Science. But most of the improvement seems to come from the AI models underneath, not from Microsoft’s system itself.

Скрыть анонс
21:07 TheVerge.com Microsoft says its AI tool is better than doctors at diagnosing conditions

Microsoft AI chief Mustafa Suleyman. | Getty Images For years, AI leaders have touted healthcare as one of the clearest examples of where their technology will improve lives. Now "it is finally here," Microsoft AI CEO Mustafa Suleyman tells The Verge. The company claims to have developed an AI-powered tool it says can diagnose conditions up to four times more accurately than human doctors. The findings, published Thursday in one of the world's most prestigious journals, Science, are based on tests pitting Microsoft's AI system against human physicians on a series of scenarios drawn from medical case reports and emergency department data. Microsoft compiled the cases into its own benchmark, S … Read the full story at The Verge.

Скрыть анонс
21:01 Phys.org Entrepreneurs live longer than salaried workers, study reveals

Conventional wisdom suggests that the long hours and pressures of entrepreneurship can take a toll on health. But new research by Cristiano Bellavitis, associate professor in the School of Business at Stevens Institute of Technology, and his collaborators finds that entrepreneurs tend to live longer than people who spend their careers working for others.

Скрыть анонс
20:31 IbTimes.co.uk Elon Musk Calls Director a 'Bitter Old Man' and Threatens to Sue Over AI Clone in New Documentary

Elon Musk threatens legal action over Alex Gibney's documentary, which uses an AI-generated likeness and faces disputes over Starlink and the 2024 US election.

Скрыть анонс
20:04 MedicalXpress.com A brain-computer interface may give unresponsive ICU patients a voice

Unresponsive ICU patients in a new Columbia study were able to raise and lower the frequency of a beeping tone with their minds, via noninvasive EEG electrodes that recorded and translated their brain waves.

Скрыть анонс
19:26 MedicalXpress.com Why using AI saves doctors time but won't fix physician burnout

AI adoption in medicine is accelerating: More than 12,000 primary care clinicians have enrolled in Canada Health Infoway's national AI scribe program, about 5,000 Ontario physicians use AI scribes and roughly one in five Canadian physicians now use AI tools. Almost 60% report a cut in administrative time.

Скрыть анонс
19:09 TechMeme.com Warp Sciences, founded by ex-OpenAI product chief Kevin Weil to speed up AI drug development, emerges from stealth with $215M at an $865M post-money valuation (Rebecca Torrence/Bloomberg)

Rebecca Torrence / Bloomberg: Warp Sciences, founded by ex-OpenAI product chief Kevin Weil to speed up AI drug development, emerges from stealth with $215M at an $865M post-money valuation  —  Kevin Weil, the former OpenAI executive who led the ChatGPT maker's AI-for-science efforts, is launching a new startup aimed …

Скрыть анонс
19:08 Endpts.com American Medical Association CEO talks regulating AI care

As we get closer to autonomous, AI-driven medical care becoming a reality, regulators are racing to catch up. The FDA in August released a discussion paper with ideas about how ...

Скрыть анонс
19:08 MedicalXpress.com Human neural stem cells found to be susceptible to SARS-CoV-2 variants

Human neural stem cells that help form the brain and spinal cord are highly susceptible to SARS-CoV-2, including omicron variants BA.1 and BA.2, according to new research from the University of California, Riverside. The findings raise concerns about the potential effects of maternal COVID-19 infection on early nervous system development and underscore the importance of monitoring children exposed to the virus before birth.

Скрыть анонс
16:58 News-Medical.Net Half-matched bone marrow transplants show high survival in young aplastic anemia patients

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Children's Center report that bone marrow transplant using half-matched family donors achieved a 96% survival rate among children, adolescent, and young adult patients with severe aplastic anemia, a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells.

Скрыть анонс
16:40 Bioengineer.org Cell study links resveratrol glucoside to mitochondrial and chromatin changes in senescence

An in-vitro study found that resveratrol glucoside reduced senescence-associated cellular changes by altering mitochondrial metabolism and chromatin regulation while showing less cytotoxicity than resveratrol.

Скрыть анонс
15:58 ScienceDaily.com People are taking an unapproved weight-loss drug. AI found something surprising

Researchers analyzing nearly 150,000 Reddit posts uncovered unexpected symptom reports linked by users to unapproved versions of retatrutide, including increased appetite, sleep disturbances, and elevated heart rates. The findings differ from clinical trial results and highlight how AI could help identify potential drug safety signals that warrant further investigation.

Скрыть анонс
15:44 Endpts.com Healthcare industry weighs in on evidence standards for generative AI medical devices

How much evidence should the FDA require before it authorizes a generative AI-enabled medical device? The question was a point of contention among healthcare lobbying organizations and tech companies, who weighed in as the FDA ...

Скрыть анонс
15:37 TASS.com Ukraine becomes global leader in black-market transplantology — envoy to OSCE

Potential and confirmed victims of human trafficking from Ukraine have been identified across Europe, Dmitry Polyansky stressed

Скрыть анонс
15:25 Bioengineer.org Natural agents and stem cells alter healing in rat skin wounds

A controlled study of 70 male rats found that stem cells led early wound contraction, while chitosan achieved the strongest contraction and marker results by day 14.

Скрыть анонс
15:25 Bioengineer.org Structure–property relationships and biological performance of electroactive biomaterial scaffolds for tissue regeneration

A review finds that electroactive tissue-regeneration scaffolds must be evaluated through linked electrical, mechanical, chemical and biological properties to address translational limitations.

Скрыть анонс
15:07 Bioengineer.org Conceptual framework links generative-AI health safeguards to five decision functions

A theory-based synthesis proposes five user and workforce functions, organizational controls and multilevel safeguards for safer decisions from conversational generative-AI health information.

Скрыть анонс
14:30 Bioengineer.org Review positions crosslinking as a multidimensional regulator of regenerative biomaterials

A review identifies crosslinking as a multidimensional design variable influencing mechanics, transport, degradation and cell interactions in preclinical biopolymer biomaterials.

Скрыть анонс
12:06 MedicalXpress.com Rebalancing the body's cellular communication system could slow aging

Researchers have outlined a plan for slowing aging by targeting one of the body's most important cellular communication systems. In a new paper published in Frontiers in Science, scientists describe how novel therapies that modulate GPCR signaling could one day help delay multiple age-related diseases at once—potentially extending healthy years of life.

Скрыть анонс
10:54 Bioengineer.org Danish Twin Study Links Rotator Cuff Tear Liability to Genetics

A nationwide Danish twin study estimated that additive genetic effects explain about half of the variation in liability to clinically diagnosed rotator cuff tears.

Скрыть анонс
09:45 Arxiv.org Statistics Self-normalized Bernstein Inequalities for Regenerative Processes and Applications to Learning Without Independence

arXiv:2610.30119v1 Announce Type: cross Abstract: We prove a self-normalized Bernstein inequality for bounded functions of a regenerative process with independent, identically distributed marked cycles of finite mean length. The bound uses observed cycle lengths and retains explicit terms for truncation and the cycle ending after the observation horizon. Selecting a tuning parameter from a finite deterministic collection gives a version of Bernstein inequality where all terms are empirical but one, related to the tails of the regeneration times. We then study this term in many regimes: it turns out that it is of second-order in many cases of interest. This is important for applications in machine learning: we prove generalization error bounds for classification with non-i.i.d., regenerative data. These bounds can be used to define learning objectives: by minimizing the first-order term only in the bound, we define agnostic classifiers that still satisfy oracle inequalities. We also

Скрыть анонс
09:45 Arxiv.org Math Self-normalized Bernstein Inequalities for Regenerative Processes and Applications to Learning Without Independence

arXiv:2610.30119v1 Announce Type: cross Abstract: We prove a self-normalized Bernstein inequality for bounded functions of a regenerative process with independent, identically distributed marked cycles of finite mean length. The bound uses observed cycle lengths and retains explicit terms for truncation and the cycle ending after the observation horizon. Selecting a tuning parameter from a finite deterministic collection gives a version of Bernstein inequality where all terms are empirical but one, related to the tails of the regeneration times. We then study this term in many regimes: it turns out that it is of second-order in many cases of interest. This is important for applications in machine learning: we prove generalization error bounds for classification with non-i.i.d., regenerative data. These bounds can be used to define learning objectives: by minimizing the first-order term only in the bound, we define agnostic classifiers that still satisfy oracle inequalities. We also

Скрыть анонс
09:45 Arxiv.org CS Self-normalized Bernstein Inequalities for Regenerative Processes and Applications to Learning Without Independence

arXiv:2610.30119v1 Announce Type: new Abstract: We prove a self-normalized Bernstein inequality for bounded functions of a regenerative process with independent, identically distributed marked cycles of finite mean length. The bound uses observed cycle lengths and retains explicit terms for truncation and the cycle ending after the observation horizon. Selecting a tuning parameter from a finite deterministic collection gives a version of Bernstein inequality where all terms are empirical but one, related to the tails of the regeneration times. We then study this term in many regimes: it turns out that it is of second-order in many cases of interest. This is important for applications in machine learning: we prove generalization error bounds for classification with non-i.i.d., regenerative data. These bounds can be used to define learning objectives: by minimizing the first-order term only in the bound, we define agnostic classifiers that still satisfy oracle inequalities. We also show

Скрыть анонс
09:45 Arxiv.org CS Closed-Loop Dual-Reference Guidance for Accent Control in Cross-Lingual Voice Cloning

arXiv:2610.29351v1 Announce Type: new Abstract: Zero-shot cross-lingual voice cloning often carries the reference speaker's accent into the target language. We propose closed-loop dual-reference guidance, which pairs the original reference with a reusable native anchor constructed by voice conversion (VC). The references initialize separate language-model (LM) states that guide a shared acoustic trajectory; each completed patch then updates both states, keeping their generated histories aligned with the emitted speech. Anchor construction runs once per speaker, and online synthesis uses a frozen TTS model without per-utterance VC. On 20 held-out French speakers, the fixed setting $\lambda^{\!*}=0.33$ reduces residual French LID mass by 73\% versus direct cloning, at an ECAPA similarity cost of only $0.042$; relative to anchor-only cloning, it recovers $0.155$. The method achieves the lowest mean WER ($0.009$) and highest mean GOP ($4.750$) among the held-out test arms. In blinded

Скрыть анонс
09:45 Arxiv.org CS Target Regeneration Shrinks the Gains of Draft-Training Objectives in Speculative Decoding

arXiv:2610.29013v1 Announce Type: new Abstract: Speculative decoding accelerates large language models by verifying drafted tokens in parallel. New draft-training objectives are usually credited with the acceptance they add over cross-entropy on externally written responses, yet many pipelines let the target rewrite them. We ask how much of that gain survives. With a vision-language target and a block drafter, we train three objectives on four versions of one corpus: cross-entropy on corpus tokens, token-level distillation from the target, and distillation gated to positions that would survive verification. Distillation and the gate add large gains on external responses, but after greedy regeneration, distillation adds a smaller gain and the gate little or none. The shrinkage persists across data orders, position weights, verifiers, decoding temperatures and, for distillation, initializations and learning rates. Most of it remains at matched supervised length and at each objective's

Скрыть анонс
09:30 Bioengineer.org The birth of the European Liver transplant registry

A historical account traces how a five-surgeon collaboration in 1985 developed into a registry containing more than 200,000 liver transplants from 174 centres across 32 European countries.

Скрыть анонс
09:30 Bioengineer.org Dual-stage motor imagery boosts brain-computer interface decoding

An offline EEG study of 97 healthy adults linked motor imagery to brief limb execution and used a dual-branch neural network to improve movement-intention decoding.

Скрыть анонс
09:07 South China Morning Post China moves to set global standards for brain-computer interface technology

China has taken a major step in spearheading the standardisation of brain-computer interface (BCI) technologies, as it now chairs the secretariat of a subcommittee jointly overseen by two key international organisations and lists the technology applications as a national development priority. The China-led subcommittee, known as ISO/IEC JTC 1/SC 43, was set to formulate global standards regarding the communication and interaction between brains and computers that are applicable across...

Скрыть анонс
08:49 Bioengineer.org AI Use Near Universal in Turkish Medical Students, but Distress Links Remain Uncertain

A cross-sectional survey of 249 medical students at one Turkish university found near-universal AI use but no stable overall link between use frequency and psychological distress.

Скрыть анонс
07:14 News-Medical.Net Stem cell therapies may need new protein quality control standards

Current Good Manufacturing Practice (GMP) standards for cell therapies assess identity, viability, sterility, and genetic stability. For extracellular vesicle (EV) products, Minimal Information for Studies of Extracellular Vesicles (MISEV2023) guidance adds particle size, concentration, markers, morphology, contaminants, endotoxin, and assays.

Скрыть анонс
05:26 Zdnet.com GridCraft is the open-source Excel clone for Linux I’ve been waiting for

If spreadsheets are your thing, but Microsoft Office isn’t, you might want to give the open-source clone, GridCraft, a try.

Скрыть анонс
05:12 TechMeme.com GM says it plans to debut OnStar AI, an in-car assistant that can execute vehicle functions and run diagnostics via voice commands, in the 2027 Cadillac Lyriq (Aarian Marshall/Wired)

Aarian Marshall / Wired: GM says it plans to debut OnStar AI, an in-car assistant that can execute vehicle functions and run diagnostics via voice commands, in the 2027 Cadillac Lyriq  —  The Detroit automaker wants your next vehicle to be a personal assistant, a best friend, and an autonomous errand-runner.

Скрыть анонс
00:31 Bioengineer.org Public Health Institutions Face AI-Flooded Information and Defunded Evidence Systems

An opinion article argues that generative AI is increasing the burden on already underfunded public health institutions that distinguish evidence from plausible but unsourced claims.

Скрыть анонс
00:31 Bioengineer.org Matrix origin determines how perlecan sugars steer stem cell fate

A laboratory study found that removing heparan sulfate chains from perlecan in cell-derived extracellular matrix altered human stem-cell differentiation according to the matrix’s cellular origin.

Скрыть анонс
21.10.2026
23:55 MedicalXpress.com Half-matched bone marrow transplant expands options for children with severe aplastic anemia

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Children's Center report that bone marrow transplant using half-matched family donors achieved a 96% survival rate among child, adolescent and young adult patients with severe aplastic anemia, a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells. The approach expands access to potentially curative treatment for patients who do not have a fully matched donor.

Скрыть анонс
23:21 Phys.org AI designs functional enzyme components that could help expand drug discovery

New active ingredients for drugs to treat infections, cancer or other serious diseases are often based on substances originally discovered in microorganisms, plants or other living organisms. Producing or improving such active ingredients in a targeted manner using microorganisms is often challenging because the underlying biological processes are extremely complex.

Скрыть анонс
23:19 Bioengineer.org Review finds CRISPR maternal–infant diagnostics not yet clinically ready

A structured review found that CRISPR diagnostics for maternal–infant HIV, hepatitis B and syphilis care remain clinically unready, with HIV early infant diagnosis offering the strongest near-term development opportunity.

Скрыть анонс
21:05 ArsTechnica.com The $15 billion ad-powered AI startup your doctor may already be using

OpenEvidence is booming despite questions about accuracy and ads.

Скрыть анонс
20:36 Bioengineer.org Copine-derived peptides advance tissue repair through programmable biomaterials

A 2026 review finds that CPNE7-derived peptides can promote selected tissue-repair processes in preclinical models when engineered into collagen and chitosan biomaterials.

Скрыть анонс
20:18 News-Medical.Net Prehabilitation program reduces death risk for frail transplant candidates

When transplant candidates become frail, doctors often worry that they are too weak to survive transplantation.

Скрыть анонс
19:43 News-Medical.Net AI scribes cut doctor paperwork but raise accuracy concerns

Artificial intelligence tools are being touted as a solution for so-called pajama time – the time doctors inevitably spend compiling patient notes after working hours.

Скрыть анонс
18:44 Nature.com (news) Cold activates a BH2 metabolic network promoting longevity and proteostasis

Скрыть анонс
18:44 Nature.com (news) Worms live longer in cool conditions thanks to a muscle-derived molecule

Скрыть анонс
18:44 Nature.com (news) Using AI to offer personalized health advice

Скрыть анонс
18:33 Nature.Com Cold activates a BH2 metabolic network promoting longevity and proteostasis

Скрыть анонс
18:33 Nature.Com Worms live longer in cool conditions thanks to a muscle-derived molecule

Скрыть анонс
18:33 Nature.Com Using AI to offer personalized health advice

Скрыть анонс
17:45 News-Medical.Net Supercomputer helps design more reliable AI for breast cancer diagnosis

While AI offers the ability to improve human experts' ability to diagnose and treat diseases like breast cancer, well-publicized errors across the broader AI field are cause for concern.

Скрыть анонс
16:32 ScienceDaily.com Rejuvenation breakthrough: Scientists reverse 60 years of aging in human cells

Scientists have turned blood cells from an 80-year-old into neural stem cells with a molecular age of less than 20, effectively reversing more than 60 years of cellular aging in the laboratory. The discovery offers a new way to investigate how cells become younger and could help researchers better understand age-related diseases such as Alzheimer's.

Скрыть анонс
16:02 Bioengineer.org Prostate cancer stem-cell targeting reviewed for therapy resistance

A narrative review identifies prostate cancer stem-like cells as plausible contributors to treatment persistence and relapse while concluding that most strategies for selectively targeting them remain experimental.

Скрыть анонс
16:02 MedicalXpress.com Fitness program for transplant candidates linked to lower mortality

When transplant candidates become frail, doctors often worry that they are too weak to survive transplantation. But according to a new study from Northwestern Medicine and the University of Pittsburgh, frailty can be significantly improved with the right personalized, physician-led fitness program.

Скрыть анонс
15:28 Bioengineer.org Stem-cell vesicles and cells alter rat response to vaginal mesh

A rat implantation study found that human umbilical cord stromal cells and their small extracellular vesicles altered selected inflammatory, fibrous and matrix-remodeling responses around vaginal mesh but did not establish clinical benefit.

Скрыть анонс
15:23 Egyptian-Gazette.com How US organ transplant system works

It’s not always patience and luck that get patients off the organ transplant waiting list and into the operating room. Unlike in many areas of medicine, experts say there’s a lot of variation in the US transplant system. Knowing there are differences and what to ask might help. “I had to ask a lot of […] The post How US organ transplant system works appeared first on Egyptian Gazette.

Скрыть анонс
Первая← Предыдущая12345678910Предыдущая →